There's Still Upside Left For Baxter International, Deutsche Bank Reports

This morning, Deutsche Bank is commenting on Baxter International Inc. (NYSE: BAX), which it said has had a nice move from the low $40s into the $50s on the back of the Octapharma recall and better results.

“We think there's still upside left into the mid-$50s given the stock's current valuation and our expectations that the current First Call Consensus estimate for 2011 are achievable,” Deutsche Bank writes.

Baxter International currently trades at $51.47.